Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
38.3%
% of IDNA's 51 holdings also in CNCR
24.0%
% of CNCR's 75 holdings also in IDNA
Overlap by Weight
Sector Drift (IDNA minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IDNA |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
GERON CORP | 2.3% | 3.0% | 2.3% |
|
REVOLUTION MEDICINES, INC. | 5.6% | 1.5% | 1.5% |
|
MERCK & CO. INC. | 4.7% | 1.5% | 1.5% |
|
EXELIXIS INC | 4.0% | 1.4% | 1.4% |
|
REGENERON PHARMACEUTICALS | 4.3% | 1.3% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to CNCR
|
SAREPTA THERAPEUTICS INC | 5.3% |
|
MODERNA, INC. | 5.0% |
|
REVOLUTION MEDICINES, INC. | 4.0% |
 |
SANOFI-AVENTIS | 3.9% |
|
INCYTE CORP | 3.8% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 3.6% |
 |
GENMAB A/S | 3.6% |
 |
ROCHE HOLDING LTD | 3.5% |
|
GILEAD SCIENCES INC | 3.4% |
|
MERCK & CO. INC. | 3.3% |
IDNA Underweight Relative to CNCR
|
ACRIVON THERAPEUTICS, INC. | -2.6% |
|
ENLIVEN THERAPEUTICS, INC. | -2.1% |
|
JANUX THERAPEUTICS, INC. | -1.8% |
|
NUVATION BIO INC CLASS A | -1.7% |
|
2SEVENTY BIO, INC. | -1.6% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | -1.5% |
|
LYELL IMMUNOPHARMA, INC. | -1.4% |
|
Y-MABS THERAPEUTICS, INC. | -1.4% |
 |
MORPHOSYS AG SPONSORED ADR | -1.4% |
|
ITEOS THERAPEUTICS, INC. | -1.4% |